Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by TheRock07on May 13, 2016 6:40am
249 Views
Post# 24869063

RE:Letter to shareholders

RE:Letter to shareholders$10 per share would not do justice to its earnings and growth profile from P2 product sales in US let alone the franchise outside the US.

My estimates of net earnings of $1.60 closely match that of the only analyst( $1.61 )

On the right out licensing deal, I foresee $20.

Plant utilization is just 35% of capacity.

Another contract deal with Horizon would not be surprising.


Bullboard Posts